 | • レポートコード：MRC2Q12-18841 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、88ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、抗ラクダ類VHH抗体のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 抗ラクダ類VHH抗体のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 抗ラクダ類VHH抗体の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 抗ラクダ類VHH抗体のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの抗ラクダ類VHH抗体の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の抗ラクダ類VHH抗体の売上および2028年までの予測に焦点を当てています。 抗ラクダ類VHH抗体のグローバル主要企業には、Genscript Biotech Corporation、Rockland Immunochemicals, Inc.、ABclonal、Eurogentec、Jackson ImmunoResearch、Southern Biotech、LSBio、Stratechなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 抗ラクダ類VHH抗体市場は、タイプとアプリケーションによって区分されます。世界の抗ラクダ類VHH抗体市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 ウエスタンブロット、ELISA 【アプリケーション別セグメント】 細胞＆遺伝子治療、遺伝子診断、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 抗ラクダ類VHH抗体製品概要 - タイプ別市場（ウエスタンブロット、ELISA） - アプリケーション別市場（細胞＆遺伝子治療、遺伝子診断、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の抗ラクダ類VHH抗体販売量予測2017-2028 - 世界の抗ラクダ類VHH抗体売上予測2017-2028 - 抗ラクダ類VHH抗体の地域別販売量 - 抗ラクダ類VHH抗体の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別抗ラクダ類VHH抗体販売量 - 主要メーカー別抗ラクダ類VHH抗体売上 - 主要メーカー別抗ラクダ類VHH抗体価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（ウエスタンブロット、ELISA） - 抗ラクダ類VHH抗体のタイプ別販売量 - 抗ラクダ類VHH抗体のタイプ別売上 - 抗ラクダ類VHH抗体のタイプ別価格 ・アプリケーション別市場規模（細胞＆遺伝子治療、遺伝子診断、その他） - 抗ラクダ類VHH抗体のアプリケーション別販売量 - 抗ラクダ類VHH抗体のアプリケーション別売上 - 抗ラクダ類VHH抗体のアプリケーション別価格 ・北米市場 - 北米の抗ラクダ類VHH抗体市場規模（タイプ別、アプリケーション別） - 主要国別の抗ラクダ類VHH抗体市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの抗ラクダ類VHH抗体市場規模（タイプ別、アプリケーション別） - 主要国別の抗ラクダ類VHH抗体市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の抗ラクダ類VHH抗体市場規模（タイプ別、アプリケーション別） - 主要国別の抗ラクダ類VHH抗体市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の抗ラクダ類VHH抗体市場規模（タイプ別、アプリケーション別） - 主要国別の抗ラクダ類VHH抗体市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの抗ラクダ類VHH抗体市場規模（タイプ別、アプリケーション別） - 主要国別の抗ラクダ類VHH抗体市場規模（トルコ、サウジアラビア） ・企業情報 Genscript Biotech Corporation、Rockland Immunochemicals, Inc.、ABclonal、Eurogentec、Jackson ImmunoResearch、Southern Biotech、LSBio、Stratech ・産業チェーン及び販売チャネル分析 - 抗ラクダ類VHH抗体の産業チェーン分析 - 抗ラクダ類VHH抗体の原材料 - 抗ラクダ類VHH抗体の生産プロセス - 抗ラクダ類VHH抗体の販売及びマーケティング - 抗ラクダ類VHH抗体の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 抗ラクダ類VHH抗体の産業動向 - 抗ラクダ類VHH抗体のマーケットドライバー - 抗ラクダ類VHH抗体の課題 - 抗ラクダ類VHH抗体の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Anti-Camelid VHH Antibody estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Anti-Camelid VHH Antibody is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Anti-Camelid VHH Antibody is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Anti-Camelid VHH Antibody is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Anti-Camelid VHH Antibody include Genscript Biotech Corporation, Rockland Immunochemicals, Inc., ABclonal, Eurogentec, Jackson ImmunoResearch, Southern Biotech, LSBio and Stratech, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Anti-Camelid VHH Antibody companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Anti-Camelid VHH Antibody market. Further, it explains the major drivers and regional dynamics of the global Anti-Camelid VHH Antibody market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Genscript Biotech Corporation
Rockland Immunochemicals, Inc.
ABclonal
Eurogentec
Jackson ImmunoResearch
Southern Biotech
LSBio
Stratech
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Anti-Camelid VHH Antibody Segment by Type
Western Blot
ELISA
Anti-Camelid VHH Antibody Segment by Application
Cell and Gene Therapy
Genetic Diagnosis
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Anti-Camelid VHH Antibody market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Anti-Camelid VHH Antibody market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Anti-Camelid VHH Antibody, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Anti-Camelid VHH Antibody, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Anti-Camelid VHH Antibody revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Anti-Camelid VHH Antibody market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Anti-Camelid VHH Antibody revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Genscript Biotech Corporation, Rockland Immunochemicals, Inc., ABclonal, Eurogentec, Jackson ImmunoResearch, Southern Biotech, LSBio and Stratech, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Anti-Camelid VHH Antibody in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-Camelid VHH Antibody companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-Camelid VHH Antibody revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-Camelid VHH Antibody Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Western Blot
1.2.3 ELISA
1.3 Market by Application
1.3.1 Global Anti-Camelid VHH Antibody Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cell and Gene Therapy
1.3.3 Genetic Diagnosis
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anti-Camelid VHH Antibody Market Perspective (2017-2028)
2.2 Anti-Camelid VHH Antibody Growth Trends by Region
2.2.1 Anti-Camelid VHH Antibody Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Anti-Camelid VHH Antibody Historic Market Size by Region (2017-2022)
2.2.3 Anti-Camelid VHH Antibody Forecasted Market Size by Region (2023-2028)
2.3 Anti-Camelid VHH Antibody Market Dynamics
2.3.1 Anti-Camelid VHH Antibody Industry Trends
2.3.2 Anti-Camelid VHH Antibody Market Drivers
2.3.3 Anti-Camelid VHH Antibody Market Challenges
2.3.4 Anti-Camelid VHH Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-Camelid VHH Antibody Players by Revenue
3.1.1 Global Top Anti-Camelid VHH Antibody Players by Revenue (2017-2022)
3.1.2 Global Anti-Camelid VHH Antibody Revenue Market Share by Players (2017-2022)
3.2 Global Anti-Camelid VHH Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti-Camelid VHH Antibody Revenue
3.4 Global Anti-Camelid VHH Antibody Market Concentration Ratio
3.4.1 Global Anti-Camelid VHH Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-Camelid VHH Antibody Revenue in 2021
3.5 Anti-Camelid VHH Antibody Key Players Head office and Area Served
3.6 Key Players Anti-Camelid VHH Antibody Product Solution and Service
3.7 Date of Enter into Anti-Camelid VHH Antibody Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-Camelid VHH Antibody Breakdown Data by Type
4.1 Global Anti-Camelid VHH Antibody Historic Market Size by Type (2017-2022)
4.2 Global Anti-Camelid VHH Antibody Forecasted Market Size by Type (2023-2028)
5 Anti-Camelid VHH Antibody Breakdown Data by Application
5.1 Global Anti-Camelid VHH Antibody Historic Market Size by Application (2017-2022)
5.2 Global Anti-Camelid VHH Antibody Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Anti-Camelid VHH Antibody Market Size (2017-2028)
6.2 North America Anti-Camelid VHH Antibody Market Size by Type
6.2.1 North America Anti-Camelid VHH Antibody Market Size by Type (2017-2022)
6.2.2 North America Anti-Camelid VHH Antibody Market Size by Type (2023-2028)
6.2.3 North America Anti-Camelid VHH Antibody Market Share by Type (2017-2028)
6.3 North America Anti-Camelid VHH Antibody Market Size by Application
6.3.1 North America Anti-Camelid VHH Antibody Market Size by Application (2017-2022)
6.3.2 North America Anti-Camelid VHH Antibody Market Size by Application (2023-2028)
6.3.3 North America Anti-Camelid VHH Antibody Market Share by Application (2017-2028)
6.4 North America Anti-Camelid VHH Antibody Market Size by Country
6.4.1 North America Anti-Camelid VHH Antibody Market Size by Country (2017-2022)
6.4.2 North America Anti-Camelid VHH Antibody Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Anti-Camelid VHH Antibody Market Size (2017-2028)
7.2 Europe Anti-Camelid VHH Antibody Market Size by Type
7.2.1 Europe Anti-Camelid VHH Antibody Market Size by Type (2017-2022)
7.2.2 Europe Anti-Camelid VHH Antibody Market Size by Type (2023-2028)
7.2.3 Europe Anti-Camelid VHH Antibody Market Share by Type (2017-2028)
7.3 Europe Anti-Camelid VHH Antibody Market Size by Application
7.3.1 Europe Anti-Camelid VHH Antibody Market Size by Application (2017-2022)
7.3.2 Europe Anti-Camelid VHH Antibody Market Size by Application (2023-2028)
7.3.3 Europe Anti-Camelid VHH Antibody Market Share by Application (2017-2028)
7.4 Europe Anti-Camelid VHH Antibody Market Size by Country
7.4.1 Europe Anti-Camelid VHH Antibody Market Size by Country (2017-2022)
7.4.2 Europe Anti-Camelid VHH Antibody Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-Camelid VHH Antibody Market Size (2017-2028)
8.2 Asia-Pacific Anti-Camelid VHH Antibody Market Size by Type
8.2.1 Asia-Pacific Anti-Camelid VHH Antibody Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Anti-Camelid VHH Antibody Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Anti-Camelid VHH Antibody Market Share by Type (2017-2028)
8.3 Asia-Pacific Anti-Camelid VHH Antibody Market Size by Application
8.3.1 Asia-Pacific Anti-Camelid VHH Antibody Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Anti-Camelid VHH Antibody Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Anti-Camelid VHH Antibody Market Share by Application (2017-2028)
8.4 Asia-Pacific Anti-Camelid VHH Antibody Market Size by Region
8.4.1 Asia-Pacific Anti-Camelid VHH Antibody Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Anti-Camelid VHH Antibody Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anti-Camelid VHH Antibody Market Size (2017-2028)
9.2 Latin America Anti-Camelid VHH Antibody Market Size by Type
9.2.1 Latin America Anti-Camelid VHH Antibody Market Size by Type (2017-2022)
9.2.2 Latin America Anti-Camelid VHH Antibody Market Size by Type (2023-2028)
9.2.3 Latin America Anti-Camelid VHH Antibody Market Share by Type (2017-2028)
9.3 Latin America Anti-Camelid VHH Antibody Market Size by Application
9.3.1 Latin America Anti-Camelid VHH Antibody Market Size by Application (2017-2022)
9.3.2 Latin America Anti-Camelid VHH Antibody Market Size by Application (2023-2028)
9.3.3 Latin America Anti-Camelid VHH Antibody Market Share by Application (2017-2028)
9.4 Latin America Anti-Camelid VHH Antibody Market Size by Country
9.4.1 Latin America Anti-Camelid VHH Antibody Market Size by Country (2017-2022)
9.4.2 Latin America Anti-Camelid VHH Antibody Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-Camelid VHH Antibody Market Size (2017-2028)
10.2 Middle East & Africa Anti-Camelid VHH Antibody Market Size by Type
10.2.1 Middle East & Africa Anti-Camelid VHH Antibody Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Anti-Camelid VHH Antibody Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Anti-Camelid VHH Antibody Market Share by Type (2017-2028)
10.3 Middle East & Africa Anti-Camelid VHH Antibody Market Size by Application
10.3.1 Middle East & Africa Anti-Camelid VHH Antibody Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Anti-Camelid VHH Antibody Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Anti-Camelid VHH Antibody Market Share by Application (2017-2028)
10.4 Middle East & Africa Anti-Camelid VHH Antibody Market Size by Country
10.4.1 Middle East & Africa Anti-Camelid VHH Antibody Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Anti-Camelid VHH Antibody Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Genscript Biotech Corporation
11.1.1 Genscript Biotech Corporation Company Details
11.1.2 Genscript Biotech Corporation Business Overview
11.1.3 Genscript Biotech Corporation Anti-Camelid VHH Antibody Introduction
11.1.4 Genscript Biotech Corporation Revenue in Anti-Camelid VHH Antibody Business (2017-2022)
11.1.5 Genscript Biotech Corporation Recent Developments
11.2 Rockland Immunochemicals, Inc.
11.2.1 Rockland Immunochemicals, Inc. Company Details
11.2.2 Rockland Immunochemicals, Inc. Business Overview
11.2.3 Rockland Immunochemicals, Inc. Anti-Camelid VHH Antibody Introduction
11.2.4 Rockland Immunochemicals, Inc. Revenue in Anti-Camelid VHH Antibody Business (2017-2022)
11.2.5 Rockland Immunochemicals, Inc. Recent Developments
11.3 ABclonal
11.3.1 ABclonal Company Details
11.3.2 ABclonal Business Overview
11.3.3 ABclonal Anti-Camelid VHH Antibody Introduction
11.3.4 ABclonal Revenue in Anti-Camelid VHH Antibody Business (2017-2022)
11.3.5 ABclonal Recent Developments
11.4 Eurogentec
11.4.1 Eurogentec Company Details
11.4.2 Eurogentec Business Overview
11.4.3 Eurogentec Anti-Camelid VHH Antibody Introduction
11.4.4 Eurogentec Revenue in Anti-Camelid VHH Antibody Business (2017-2022)
11.4.5 Eurogentec Recent Developments
11.5 Jackson ImmunoResearch
11.5.1 Jackson ImmunoResearch Company Details
11.5.2 Jackson ImmunoResearch Business Overview
11.5.3 Jackson ImmunoResearch Anti-Camelid VHH Antibody Introduction
11.5.4 Jackson ImmunoResearch Revenue in Anti-Camelid VHH Antibody Business (2017-2022)
11.5.5 Jackson ImmunoResearch Recent Developments
11.6 Southern Biotech
11.6.1 Southern Biotech Company Details
11.6.2 Southern Biotech Business Overview
11.6.3 Southern Biotech Anti-Camelid VHH Antibody Introduction
11.6.4 Southern Biotech Revenue in Anti-Camelid VHH Antibody Business (2017-2022)
11.6.5 Southern Biotech Recent Developments
11.7 LSBio
11.7.1 LSBio Company Details
11.7.2 LSBio Business Overview
11.7.3 LSBio Anti-Camelid VHH Antibody Introduction
11.7.4 LSBio Revenue in Anti-Camelid VHH Antibody Business (2017-2022)
11.7.5 LSBio Recent Developments
11.8 Stratech
11.8.1 Stratech Company Details
11.8.2 Stratech Business Overview
11.8.3 Stratech Anti-Camelid VHH Antibody Introduction
11.8.4 Stratech Revenue in Anti-Camelid VHH Antibody Business (2017-2022)
11.8.5 Stratech Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer